Rani Therapeutics Holdings (RANI) Net Equity Issued and Repurchased (2024 - 2025)

Rani Therapeutics Holdings (RANI) posted quarterly Net Equity Issued and Repurchased of $8.9 million for Q4 2024.

Rani Therapeutics Holdings (RANI) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends

Rani Therapeutics Holdings' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $8.9 million for Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	49.20 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Rani Therapeutics Holdings	163.98 Mn	163.98 Mn	-	-

Download Data